The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer

by Marloes A Smit, Wilma E Mesker
Published 2020-11-01

Detection of Tumor Cells in Bone Marrow, Peripheral Blood and Lymph Nodes by Automated Imaging Devices

by Wilma E. Mesker, Hans Vrolijk, Willem C. R. Sloos, Rob A. E. M. Tollenaar, Hans J. Tanke
Published 2006-01-01

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

by Tessa P. Sandberg, Maaike P. M. E. Stuart, Jan Oosting, Rob A. E. M. Tollenaar, Cornelis F. M. Sier, Wilma E. Mesker
Published 2019-03-01

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

by Wilma E. Mesker, Jan M. C. Junggeburt, Karoly Szuhai, Pieter de Heer, Hans Morreau, Hans J. Tanke, Rob A. E. M. Tollenaar
Published 2007-01-01

Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs

by André M. Deelder, Rob A. E. M. Tollenaar, Bart J. Mertens, Yuri E. M. van der Burgt, Anouck Huijbers, Tim J. A. Dekker, Wilma E. Mesker, Berit Velstra
Published 2010-10-01

Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort

by Thomas P. Potjer, Bart J. Mertens, Simone Nicolardi, Yuri E. M van der Burgt, Bert. A. Bonsing, Wilma E. Mesker, Rob A. E. M Tollenaar, Hans F. A Vasen
Published 2016-06-01

Stromal targets for fluorescent-guided oncologic surgery

by Martin C. Boonstra, Jai ePrakash, Cornelis J.H. van de Velde, Wilma E. Mesker, Peter J.K. Kuppen, Alexander L. Vahrmeijer, Cornelis F.M. Sier, Cornelis F.M. Sier
Published 2015-11-01

A Matrix-Assisted Laser Desorption/Ionization—Mass Spectrometry Assay for the Relative Quantitation of Antennary Fucosylated N-Glycans in Human Plasma

by Osmond D. Rebello, Osmond D. Rebello, Simone Nicolardi, Guinevere S. M. Lageveen-Kammeijer, Jan Nouta, Richard A. Gardner, Wilma E. Mesker, Rob A. E. M. Tollenaar, Daniel I. R. Spencer, Manfred Wuhrer, David Falck
Published 2020-02-01

Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer

by Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar
Published 2021-03-01

Parelsnoer Institute Biobank Hereditary Colorectal Cancer: A Joint Infrastructure for Patient Data and Biomaterial on Hereditary Colorectal Cancer in the Netherlands

by Peggy Manders, Janet R. Vos, Richarda M. de Voer, Liselot P. van Hest, Rolf Sijmons, Chantal V. Hoge, Fokke G. Terpstra, Manon C. Spaander, Wilma E. Mesker, Evelien Dekker, Nicoline Hoogerbrugge, on behalf of the Biobank Hereditary Colorectal Cancer
Published 2019-04-01

Serum N‐Glycome analysis reveals pancreatic cancer disease signatures

by Gerda C. M. Vreeker, Randa G. Hanna‐Sawires, Yassene Mohammed, Marco R. Bladergroen, Simone Nicolardi, Viktoria Dotz, Jan Nouta, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van derBurgt, Manfred Wuhrer, Rob A. E. M. Tollenaar
Published 2020-11-01

Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients

by Wilma E. Mesker, Gerrit-Jan Liefers, Jan M. C. Junggeburt, Gabi W. van Pelt, Paola Alberici, Peter J. K. Kuppen, Noel F. Miranda, Karin A. M. van Leeuwen, Hans Morreau, Karoly Szuhai, Rob A. E. M. Tollenaar, Hans J. Tanke
Published 2009-01-01